🔎 Trials Near Me

Home › Follicular Lymphoma › Indiana

Pag-aaral pangklinika para sa Follicular Lymphoma sa Indiana

7 pag-aaral para sa Follicular Lymphoma ang naghahanap ng mga kalahok sa mga site sa Indiana.

Mga Lungsod sa Indiana

Opisyal na teksto ng pag-aaral (English)

5HTP Regulation Of Asthma In Children

  • Indiana University, Indianapolis
Nagre-recruitPhase 2
Edad 8 hanggang 18 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT04160910

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

  • Research Site, Fort Wayne
Nagre-recruitPhase 3
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06549595

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

  • Investigative Clinical Research of Indiana, Noblesville
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06091254

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • Indiana University, Indianapolis
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • Indiana Blood and Marrow Transplantation, Indianapolis
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

  • Indiana University and Comprehensive Cancer Center, Indianapolis
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT06149286

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

  • American Oncology Partners, Fort Wayne
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 10, 2025 · NCT05602363

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.